AzTrials
AzTrials

Cesarean SectionNCT02899260

Using the Peanut Exercise Ball to Reduce Cesarean Section Rates: A Randomized Controlled Trial

A study testing Peanut Exercise Ball in people with Cesarean Section, run by Virginia Commonwealth University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is designed as a prospective, randomized controlled trial that will compare the use of the peanut exercise ball in laboring patients compared with no use of the exercise ball. We hypothesize that use of the peanut ball decreases the incidence of cesarean section. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Cesarean Section
What is being tested?
Peanut Exercise Ball
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
316 participants
Where
1 siteUnited States
Study dates
Aug 2016to 10 Apr 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Inclusion Criteria for this study include pregnant women over the age of 18 who present to VCU Labor and Delivery in labor or for induction of labor with a fetus in cephalic presentation.

Who cannot join

  • Exclusion criteria for this study include women with multifetal gestations, fetus in breech or transverse position, musculoskeletal abnormalities in the mother which might preclude them from proper positioning on the peanut ball.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • VCU Health System

    Richmond, Virginia, 23298

Other trials in United States

About this study

This study is designed as a prospective, randomized controlled trial that will compare the use of the peanut exercise ball in laboring patients compared with no use of the exercise ball. We hypothesize that use of the peanut ball decreases the incidence of cesarean section.

Read the detailed description

This study is designed as a prospective, randomized controlled trial that will compare the use of the peanut exercise ball in laboring patients compared with no use of the exercise ball. The investigators plan to include all pregnant women over the age of 18 who present to VCU Labor and Delivery in labor or for induction of labor with a fetus in cephalic presentation. They will have the peanut shaped exercise ball placed between the maternal legs in either the supine or upright position during labor. The peanut ball can be seen at this link, which is similar to the ball the investigators use on Labor and Delivery (http://www.amazon.com/Isokinetics-Inc-Brand-Peanut-Ball/dp/B0026N2JWG). We use various sizes of this durable, non-latex exercise ball. There is a small size (for women ,5'3" that is 40inches), medium size for women 5'3" to 5'"7 (50inches) and a large for women >5'7" (60inches). The length of time using the peanut ball will be quantified by charting in OB TraceVue software (which is currently standard practice with peanut ball use).

Each patient will be assigned a number in order starting at 1. Each patient will then be randomized using a block randomization scheme with pre-assigned envelopes in the labor and delivery team room starting at number 1. Each participant will have an envelope pulled in order of their number assignment when admitted to labor and delivery and consent obtained.

Exclusion criteria for this study include women with multifetal gestations, fetus in breech or transverse position, musculoskeletal abnormalities in the mother which might preclude them from proper positioning on the peanut ball.

This study is a prospective, two-armed randomized controlled trial (RCT) with interim analyses planned after 50% and 75% of the patients have completed the study. Using nTerim 2.0, 2000 total subjects (1000 per group) will be needed to have a study powered at 80% to detect a difference in the C-section rate if the treatment and control groups have C-section rates of 11.25% and 15%, respectively, using a one-sided test at the 0.05 level. The primary outcome will be the observed incidence of cesarean section delivery in the two populations of randomized, laboring women.

Bayesian stopping rules, for expected success and futility, are to be added to this study. Bayesian stopping rules have advantages over other traditional types of interim analyses. Specifically, they can be used for Bayesian or frequentist (e.g. traditional) trial designs without requiring the statistical analysis or study design to be altered. Additionally, the study is not penalized for additional 'looks' at the data, as is the case in traditional interim analyses. A drawback of this strategy is that the methods used to analyze the data (e.g. frequentist and Bayesian) have different interpretations and may not come to the same conclusion.

The investigators plan on conducting three interim analyses, after sample sizes of 500, 1000, and 1500 have been achieved. At each look, the predicted probability of trial success, assuming the full 2004 subjects are accrued, will be calculated. The predictive probability is defined as the probability that the unanticipated C-section rate for the Peanut Ball (PB) group is lower than that of the control (C), as measured assuming the full 2004 subjects are accrued and conditional on the data obtained from the subjects that the study has already accrued. If this probability is small (e.g. < 0.10), then the study will stop for futility. If the predicted probability with the current sample size is large, meaning it is likely that the Peanut ball group has a lower unanticipated C-section rate, then the study will be stopped for expected success. Predicted probabilities of 0.95, 0.90, and 0.90 for the interim analyses at 500, 1000, and 1500 subjects will be used to determine expected success, respectively. If neither of these conditions are met, the study will continue to accrue subjects until a maximum of 2004 subjects.

The calculation of the predictive probabilities are slightly different for futility and trial success. For the futility analysis, the posterior distribution of an unanticipated C-section will be will be specified as a beta distribution with Xig +1 and Nig - Xig +1 degrees of freedom (Beta(Xig +1, Nig - Xig +1)), where Xig denotes the total number of unanticipated C-sections for the group g (PB, C) for assessment i (1,2,3) from the total sample size in each group (Nig). This distribution comes from the commonly used beta-binomial posterior distribution using and uninformative (uniform) prior. For each treatment group and interim analysis, an unanticipated C-section rate will be simulated from the respective posterior distribution (pigj) and, based on this simulated value, a simulated number of additional unanticipated C-sections will be calculated. This process will repeat itself 10,000 times, and for each iteration, the total estimated rate of unanticipated C-sections will be calculated. The posterior probability for futility, P(pi,PB+0.0375<pi,C) after accruing the total 2004 subjects will be calculated by summing up the instances where pi,PBj+0.0375<pi,Cj, where pi,gj is the predictive probability of an unanticipated C-section after full enrollment for simulation j. The offset, 0.0375, is calculated from the hypothesized difference from the original power analysis (0.15-0.1125=0.0375)

A similar process will be used for efficacy, however, the predictive probability will be calculated from the inequality P(pi,PB<pi,C).

The investigators will collect the data, perform data entry and review charts to ensure accuracy of information. Medical Record Numbers will be collected with data collection to ensure that we can adequately review the chart of the patient for data collection.The investigators will also collect information on mode of delivery (vaginal, operative vaginal, csection), gravidity, parity, age, bmi, epidural anesthesia (yes/no), induction vs spontaneous labor, gestational age at delivery, dilation at admission, fetal position at delivery, birth weight, cord ph, Apgars, dystocia, length of active phase of labor and second stage of labor.

Being tested
Peanut Exercise Ball

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Peanut Exercise BallDevice

    A Peanut shaped exercise ball.

Study groups in NCT02899260
Study groupRoleWhat they receive
ControlNo interventionSubjects who are randomized to to the control group will labor without the use of the peanut ball in labor.
Experimental/Peanut BallExperimentalSubjects randomized to the intervention (peanut ball) arm will have the peanut ball planed between their upper legs for at least 30minutes during their labor. Time on the peanut ball will be quantified by the bedside nursing staff.
Receives: Device: Peanut Exercise Ball

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cesarean Section

    Vaginal birth versus cesarean section

    Measured: Labor outcome during hospitalization for labor (1-3 days)

Secondary outcomes (4)
  1. Fetal APGAR Scores

    1 minute and 5minute APGAR scores

    Measured: Delivery to 5 minutes following delivery

  2. Labor Duration

    Time of active phase of labor and time of second stage of labor

    Measured: Labor (1-3days)

  3. Fetal cord Ph

    Cord Ph obtained immediately following delivery

    Measured: Immediately following delivery

  4. Mode of vaginal delivery

    Spontaneous versus operative vaginal delivery with forceps or vacuum

    Measured: Delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2016 (estimated)
  2. Study startAug 2016
  3. Primary completion10 Apr 2019
  4. Study completion10 Apr 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
316 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02899260
Sponsor's protocol ID
HM20006455
Status last verified
Sep 2020
First submitted
8 Sep 2016
Last updated
22 Sep 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Plan to make individual data available on clinical trials.gov at conclusion of study.

Questions about this trial

What is this clinical trial studying?

A study testing Peanut Exercise Ball in people with Cesarean Section, run by Virginia Commonwealth University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cesarean Section (time frame: Labor outcome during hospitalization for labor (1-3 days)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2020.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in